[HTML][HTML] Type II diabetes mellitus: a review on recent drug based therapeutics

S Padhi, AK Nayak, A Behera - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Diabetes mellitus (DM) is a metabolic disorder that occurs in the body because of decreased
insulin activity and/or insulin secretion. Pathological changes such as nephropathy …

[HTML][HTML] Management of type 2 diabetes: current strategies, unfocussed aspects, challenges, and alternatives

SP Borse, AS Chhipa, V Sharma, DP Singh… - Medical Principles and …, 2021 - karger.com
Type 2 diabetes mellitus (T2DM) accounts for> 90% of the cases of diabetes in adults.
Resistance to insulin action is the major cause that leads to chronic hyperglycemia in …

From diabetes to atherosclerosis: potential of metformin for management of cardiovascular disease

AV Poznyak, L Litvinova, P Poggio… - International journal of …, 2022 - mdpi.com
Atherosclerosis is a common cause of cardiovascular disease, which, in turn, is often fatal.
Today, we know a lot about the pathogenesis of atherosclerosis. However, the main …

[HTML][HTML] DAPAGLIFLOZIN: A NEW HOPE FOR THE THERAPEUTIC TREATMENT OF TYPE 2 DIABETES MELLITUS

N Maksud, S Bera, MJ Naim, O Alam - European Journal of Medicinal …, 2024 - Elsevier
Diabetes mellitus (Type 2) is a major world health problem spreading speedily throughout
the world. It is a chronic illness that necessitates long-term therapy and care. Therefore, the …

Nanotechnology in diabetes Management: Revolutionizing treatment and diagnostics

K Yadav - Journal of Molecular Liquids, 2024 - Elsevier
The global health landscape is witnessing a paradigm shift as diabetes emerges as a
formidable challenge to conventional medical interventions. This metabolic disorder …

RSSDI consensus recommendations on insulin therapy in the management of diabetes

R Chawla, BM Makkar, S Aggarwal, S Bajaj… - International Journal of …, 2019 - Springer
Abstract The Research Society for the Study of Diabetes in India (RSSDI) has regularly
updated its Clinical Practice Guidelines on various aspects of diabetes. The …

Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use

AC Lopes, O Lourenço, S Morgado, A Gaspar, I Freire… - Pharmaceuticals, 2024 - mdpi.com
Dapagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2i), has shown
demonstrated benefits for renal and cardiovascular outcomes in large clinical trials …

Microalgae as a potential sustainable solution to environment health

HSH Munawaroh, F Hazmatulhaq, GG Gumilar… - Chemosphere, 2022 - Elsevier
Cyanobacteria such as Spirulina platensis secretes numerous biomolecules while
consuming CO 2 for photosynthesis which can reduce the environmental pollution as it can …

Dapagliflozin, a sodium glucose cotransporter 2 inhibitors, protects cardiovascular function in type-2 diabetic murine model

S Saleh, G Hanna, SH El-Nabi, H El-Domiaty… - Journal of Genetics, 2020 - Springer
Diabetes mellitus and its complications are major international health problems in which
there are many limitations to the orthodox approaches in the treatment. Sodium glucose …

Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update

A Kumar, R Mazumder, A Rani… - Current Diabetes …, 2024 - ingentaconnect.com
Diabetes mellitus is an irreversible, chronic metabolic disorder indicated by hyperglycemia.
It is now considered a worldwide pandemic. T2DM, a spectrum of diseases initially caused …